- Home
- GALT vs NEN Comparison
GALT vs NEN Comparison
Compare GALT & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- NEN
- Stock Information
- Founded
- GALT 2000
- NEN 1977
- Country
- GALT United States
- NEN United States
- Employees
- GALT N/A
- NEN N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- NEN Building operators
- Sector
- GALT Health Care
- NEN Real Estate
- Exchange
- GALT Nasdaq
- NEN Nasdaq
- Market Cap
- GALT 232.3M
- NEN 262.4M
- IPO Year
- GALT N/A
- NEN N/A
- Fundamental
- Price
- GALT $4.60
- NEN $72.00
- Analyst Decision
- GALT Strong Buy
- NEN
- Analyst Count
- GALT 3
- NEN 0
- Target Price
- GALT $6.00
- NEN N/A
- AVG Volume (30 Days)
- GALT 241.8K
- NEN 490.0
- Earning Date
- GALT 08-14-2025
- NEN 01-01-0001
- Dividend Yield
- GALT N/A
- NEN 6.67%
- EPS Growth
- GALT N/A
- NEN 34.86
- EPS
- GALT N/A
- NEN 4.59
- Revenue
- GALT N/A
- NEN $83,884,808.00
- Revenue This Year
- GALT N/A
- NEN N/A
- Revenue Next Year
- GALT N/A
- NEN N/A
- P/E Ratio
- GALT N/A
- NEN $15.69
- Revenue Growth
- GALT N/A
- NEN 4.96
- 52 Week Low
- GALT $0.73
- NEN $71.00
- 52 Week High
- GALT $4.71
- NEN $84.00
- Technical
- Relative Strength Index (RSI)
- GALT 69.41
- NEN 50.10
- Support Level
- GALT $3.93
- NEN $71.00
- Resistance Level
- GALT $4.35
- NEN $72.00
- Average True Range (ATR)
- GALT 0.27
- NEN 0.08
- MACD
- GALT 0.03
- NEN 0.16
- Stochastic Oscillator
- GALT 91.67
- NEN 100.00
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.